B1.617.2 Variant
- All
- News
- Videos
-
Delta Variant Predominant Despite Complete, Partial Vaccination: Study
A preliminary study conducted by the All India Institute of Medical Science (AIIMS), Delhi claimed that the presence of COVID-19 Delta variant (B1.617.2) is predominantly found even after the first dose or both doses of vaccine has been administered.
-
UK Issues Localised Directions To Tackle Covid Strain Found In India
The UK government on Tuesday faced accusations of "confusion and uncertainty" after it introduced additional guidance to curtail non-essential travel in and out of so-called hotspots of the B1.617.2 variant of concern (VOC), first identified in India
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
Nothing "Conclusive" On India-Dominant Variant To Delay Reopening: UK PM
UK Prime Minister Boris Johnson said there is nothing conclusive yet that indicates that B1.617.2 variant of COVID-19 would force Britain to deviate from its roadmap to lift lockdown restrictions fully next month.
-
Surge Tests, Jab Measures As India-Dominant Covid Variant Spreads In UK
The case numbers related to the B1.617.2 variant of COVID-19, first identified in India, have more than doubled within a week in the UK, resulting in further surge testing and enhanced vaccine measures to be deployed in parts of the country
-
Delta Variant Predominant Despite Complete, Partial Vaccination: Study
A preliminary study conducted by the All India Institute of Medical Science (AIIMS), Delhi claimed that the presence of COVID-19 Delta variant (B1.617.2) is predominantly found even after the first dose or both doses of vaccine has been administered.
-
UK Issues Localised Directions To Tackle Covid Strain Found In India
The UK government on Tuesday faced accusations of "confusion and uncertainty" after it introduced additional guidance to curtail non-essential travel in and out of so-called hotspots of the B1.617.2 variant of concern (VOC), first identified in India
-
Oxford, Pfizer Vaccines 80% Effective On Variant Found In India: Study
Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant of COVID-19, first discovered in India, a new UK government study has reportedly found.
-
Nothing "Conclusive" On India-Dominant Variant To Delay Reopening: UK PM
UK Prime Minister Boris Johnson said there is nothing conclusive yet that indicates that B1.617.2 variant of COVID-19 would force Britain to deviate from its roadmap to lift lockdown restrictions fully next month.
-
Surge Tests, Jab Measures As India-Dominant Covid Variant Spreads In UK
The case numbers related to the B1.617.2 variant of COVID-19, first identified in India, have more than doubled within a week in the UK, resulting in further surge testing and enhanced vaccine measures to be deployed in parts of the country
